Latest News

Keep up to date with all our latest investments, service offerings and news items.

• October 28, 2024

  Almac Pharma Services Announces Recruitment Event Following Major Expansion at Craigavon HQ

• October 1, 2024

  Almac Group announces £11m investment to expand global analytical services 

• September 30, 2024

  Almac Pharma Services Appoints New VP Finance

• August 30, 2024

  Almac Pharma Services Joins European Paediatric Formulation Initiative (EuPFI)

• July 23, 2024

  Almac Pharma Services Announces Successful FDA Inspection at Charnwood, UK Facilities

• June 18, 2024

  Almac Pharma Services Supports Rapid Launch of BioLineRx’s APHEXDA® (motixafortide)

• June 4, 2024

  Almac Pharma Services Appoints New VP of Business Development

• April 30, 2024

  Almac Pharma Services Supports Industry Consortium to Address Titanium Dioxide Alternative Challenge

• April 22, 2024

  Amicus Therapeutics Inc and Almac Pharma Services Mark 15-year Strategic Partnership with Patient Advocacy Event

• April 4, 2024

  Almac Pharma Services Appoints New Director of Manufacturing Science and Technology

• March 20, 2024

  Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia

• March 12, 2024

  Almac Group Awarded six 2024 CDMO Leadership Awards

• February 12, 2024

  Almac Pharma Services Renew HPRA GMP Certification  for European Facility

• November 14, 2023

  Almac Pharma Services Receives Brazilian ANVISA GMP Certification for US Facility

• October 19, 2023

  Almac Group releases details of £80 million expansion in Northern Ireland

• May 12, 2023

  Almac Pharma Services Hosts Recruitment Open Day in Loughborough

• March 24, 2023

  Technical Quality Team Leaders Graduate with Masters in Pharmaceutical Validation Technology

• February 21, 2023

  Almac Group Awarded with Six CDMO Leadership Awards Across all Core Categories

• January 23, 2023

  Almac Pharma Services Announces Two Vice President Appointments

• January 12, 2023

  Almac Pharma Services Recruiting Senior Operators in Charnwood

• December 13, 2022

  Almac Pharma Services Supports Rapid Launch of Provention Bio, Inc.’s Treatment TZIELD™ (teplizumab-mzwv)

• October 17, 2022

  Almac Pharma Services Supports Packaging and Supply of PTC Therapeutics’ Gene Therapy Upstaza™ for EU Launch

• October 4, 2022

  Almac Group Announces New COO and Appoints New Almac Pharma Services MD

• February 1, 2022

  Almac Group Recognised in Life Science Leader CMO Awards for the Eighth Time

• July 6, 2021

  Almac Group’s Charnwood Site Achieves Globally Recognised Health & Safety and Environmental Management System Certifications

• June 16, 2021

  Almac Pharma Services Launches Trainee Recruitment Drive

• September 25, 2019

  Almac Pharma Services Achieves Unprecedented Global Regulatory Milestone

• March 26, 2019

  Almac Group Recognised with Six Life Science Leader CMO Awards

• October 2, 2018

  Almac Group Announces Successful HPRA Inspection at its European Campus

• August 27, 2018

  Almac Group Appoints New Site Head for Charnwood Campus, Loughborough, UK

• July 25, 2018

  Almac Group Appoints Three Vice Presidents

• April 16, 2018

  Almac Group Expands US Specialised Commercial Packaging Capabilities

• October 23, 2017

  Almac Group Announces Successful MHRA Inspection at Charnwood Facilities

• November 14, 2016

  Almac Group Expands Commercial Capabilities to Meet Industry Demand for Paediatric Formulations

• November 9, 2015

  Almac Group announces significant expansion in pharmaceutical development capacity

• October 23, 2013

  Almac invests to accelerate formulation development services

• January 14, 2013

  Almac Doubles Drug Product Development Capacity with a New Non-GMP Facility

• October 20, 2011

  Almac Announces Expansion of Pharmaceutical Development Facilities

• May 11, 2011

  Almac to host inaugural European Product Launch workshop for US Biopharmaceutical Companies

• April 19, 2010

  Almac completes its expansion plan to Pharma Services facilities

• February 10, 2010

  Almac adds Xcelodose® 600S Precision Powder Micro-dosing System to its Product Development Capabilities

• June 30, 2009

  Almac Completes Phase 1 of its Expansion Plan to Pharma Services Facilities

• November 10, 2006

  Almac Pharma Services Extend Formulation Facilities

• March 20, 2006

  PDMS Extend Formulation Development Facility

• May 9, 2005

  PDMS Awards Major Pharmaceuticals Manufacturing System Contract to SSI